Inventor · disambiguated record
Chad A. Vanhuis
Also filed as: VANHUIS CHAD A
15 granted patents·3 pending applications·54 citations·filing 2014–2020
90Inventor score
Top patents by PatentIndex Score
18 records- 0192US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0292US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0392US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 0491US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 0587US9896441B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2015·Granted Feb 20, 2018·6 cites·58 claims
- 0685US9580388B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Feb 28, 2017·4 cites·27 claims
- 0780US10442798B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2018·Granted Oct 15, 2019·2 cites·30 claims
- 0880US10364237B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Jul 30, 2019·2 cites·20 claims
- 0979US10421751B2Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Sep 24, 2019·2 cites·26 claims
- 1075US9932313B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2017·Granted Apr 3, 2018·1 cites·25 claims
- 1173US10611740B2Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Apr 7, 2020·1 cites·44 claims
- 1268US9815791B2Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2014·Granted Nov 14, 2017·1 cites·28 claims
- 1365US11059796B2Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseUNIV MICHIGAN REGENTS·Filed 2020·Granted Jul 13, 2021·0 cites·20 claims
- 1465US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 1559US2018334438A1Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2018·Application pending·0 cites
- 1651US10556898B2Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2019·Granted Feb 11, 2020·0 cites·31 claims
- 1746US2020207726A1Indolinyl sulfonamide and related compounds for use as agonists of rory and the treatment of diseaseLYCERA CORP·Filed 2019·Application pending·0 cites
- 1844US2021139484A1Dihydroisoquinoline-2(1h)-carboxamide and related compounds and their use in treating medical conditionsGOSSAMER BIO SERVICES INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chad A. Vanhuis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →